Ehrlich Christopher B's Form 4 filing
eFFECTOR Therapeutics, Inc. (EFTR) · filed Feb 22, 2022
- Accession no.
- 0001209191-22-011731
- Filed
- Feb 22, 2022
- Trade date
- Feb 14-18, 2022
- Filing delay
- 8 daysLate
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market purchases total $13.2K. It was filed 8 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Ehrlich Christopher BCIK 0001293973 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 14, 2022 | Common Stock | PPurchaseAcquired | +2,000 | $4.45 | +$8,900 | 15,000 | Direct | |
| Feb 18, 2022 | Common Stock | PPurchaseAcquired | +1,000 | $4.30 | +$4,300 | 16,000 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.